At Karuna, our purpose is to create and deliver transformative medicines for people living with psychiatric and neurological conditions.
Through the cultivation of our deep expertise in neuroscience, and inventive thinking around drug discovery and development, we are advancing a pipeline of novel medicines with the goal of providing a meaningful difference in the lives of those affected by these conditions.
Our culture is defined by our passion to serve those affected by mental illness. We are purpose-driven and intentional. We know impactful innovations don’t come easy, but are borne from passion and hard work. Together, we are working toward a goal bigger than ourselves.
We invite you to join us on LinkedIn and Twitter (@KarunaPharma) to stay up to date on our work.
Location: United States, Massachusetts, Boston
Employees: 51-200
Total raised: $80M
Founded date: 2009
Investors 4
| Date | Name | Website |
| - | PFM Health... | pfmhealths... |
| 17.07.2021 | ARCH Ventu... | archventur... |
| - | Sofinnova ... | sofinnova.... |
| - | NFLS - Piv... | pivotalbio... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 01.04.2019 | Series B | $80M | - |
Mentions in press and media 10
| Date | Title | Description | Source |
| 14.12.2023 | Karuna Announces The Lancet Publication of Data from Phase 3... | - | sofinnova.... |
| 29.11.2023 | Karuna Announces U.S. Food and Drug Administration Accepts N... | - | sofinnova.... |
| 25.02.2021 | Karuna Therapeutics Reports Fourth Quarter and Year End 2020... | BOSTON--(BUSINESS WIRE)--Feb 25, 2021-- Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage b... | oaoa.com/n... |
| 24.02.2021 | Karuna Therapeutics Announces New England Journal of Medicin... | BOSTON--(BUSINESS WIRE)--Feb 24, 2021-- Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage b... | oaoa.com/n... |
| 20.11.2019 | Karuna Therapeutics Announces Pricing of $250 Million Public... | - | sofinnova.... |
| 02.04.2019 | Daily funding roundup - April 2nd, 2019 | DynamiCare raised $4.1M; OnScale raised $10M; Fifth Eye Enables landed $11.5M; Perch secured $220M D... | vator.tv/n... |
| 01.04.2019 | Karuna Raises $12M; Completes $80M Series B | Karuna Therapeutics, Inc., a Boston, MA-based innovative clinical-stage biopharmaceutical company, r... | finsmes.co... |
| 19.03.2019 | Term Sheet — Tuesday, March 19 | UNICORN ALERT There’s a new unicorn on the block. Glossier, the direct-to-consumer beauty brand, rai... | fortune.co... |
| 19.03.2019 | Daily funding roundup - March 19th, 2019 | FlexClub raised $1.2M; frontdesk.ai raised $2M; Automata raised $7.4M; Tibber raised $12M FlexClub: ... | vator.tv/n... |
| 18.03.2019 | Karuna Therapeutics Raises $68M Series B Funding | Karuna Therapeutics, a Boston, MA-based clinical-stage drug development company, raised a $68m Serie... | finsmes.co... |